← Feed

Foresite Capital Fund VI LP

SEC Form 4 insider
Latigo Biotherapeutics, Inc. ($ALMS), Latigo Biotherapeutics, Inc. ($LTGO)
1 thesis · first seen Aug 17, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%-2.4%-2.4%
3d1100%-10.4%-10.4%
1w1100%-9.7%-9.7%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ALMSSEC 13Dbullish
Foresite Capital Fund VI LP · beneficial owner of Latigo Biotherapeutics, Inc. · 46d agono track record yet
Long 9,181,328 shares of ALMS
9,181,328 shares · 14.5% of class · 2026-08-10

Schedule 13D: Foresite Capital Fund VI LP disclosed a stake in ALMS

Foresite Capital Fund VI LP disclosed a 14.5% stake of 9,181,328 shares in Latigo Biotherapeutics, Inc. (ALMS) in a Schedule 13D filed 2026-08-17.

At post $25.50Now $6.95-72.8% since posted29m ago
1d-2.4%
3d-10.4%
1w-9.7%
1m-68.9%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.